LSQ Honours Visionary Biotech Leader with Hall of Fame Award
Posted: 4 December 2024 Before her death from cancer in August his year, Dr Depaz was Country Medical Lead and Head of Medical Vaccines for Sanofi Australia & New Zealand, as well as Managing Director of the Translational…
Sir Gustav Nossal Professor of Immunology to honour giant of Australian science
Posted: 4 December 2024 The exceptional research, discovery and advocacy legacy of former WEHI director and Australian treasure Sir Gustav Nossal AC CBE will continue through an ongoing professorship, announced today by WEHI and the Nossal family. Launched with a…
Alterity Therapeutics Completes Last Patient Visit in ATH434-201 Phase 2 Clinical Trial in Early-Stage Multiple System Atrophy
Posted: 4 December 2024 Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that the last patient in the ATH434-201 Phase 2 trial,…
Optiscan inks deal with US uni to diagnose cancer in animals
Posted: 27 November 2024 Optiscan has been featured in Stockhead and The Australian regarding its partnership with the University of Minnesota to advance cancer detection in pets. This collaboration focuses on utilizing Optiscan’s confocal endomicroscope imaging system to…
Promising daily tablet increases growth in children with dwarfism
Posted: 27 November 2024 A promising daily tablet is effective at increasing height and improving proportional limb growth in children with achondroplasia, the most common form of dwarfism, according to a new study. And the findings could spare…
Moderna Announces The Awardees For Its 2024 Australia Fellowship Program, Supporting World-Class mRNA Science In Australia
Posted: 27 November 2024 Moderna, Inc (NASDAQ: MRNA), today announced the awardees of its 2024 Australia Fellowship Program. The program, in its second year, is dedicated to developing the country’s world-leading health and medical research sector in mRNA…
Immutep’s Efti Shows Excellent Survival Data from INSIGHT-003 Trial in Non-Small Cell Lung Cancer
Posted: 27 November 2024 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces positive data from the investigator-initiated INSIGHT-003 Phase I trial evaluating…
Merck and Digital Trust Centre at NTU Singapore, collaborate to Enable Digital Trust
Posted: 27 November 2024 Merck, a leading science and technology company, and Digital Trust Centre (DTC) at Nanyang Technological University, Singapore (NTU Singapore) are collaborating to pioneer a new digital trust technology designed to enable secure, automated, traceable…
Introducing FlexFactory to Poland, delivered by Cytiva and operated by SyVento Biotech
Posted: 27 November 2024 SyVento Biotech has opened its new mRNA manufacturing facility, a FlexFactory delivered by Cytiva, spanning over 7 000 m2, including lab and production areas, offices, and shared spaces. This development represents a significant milestone…
$10 million boost from Australian Cancer Research Foundation for state-of-the-art scanning technology
Posted: 27 November 2024 Australian Cancer Research Foundation (ACRF) has awarded a $10 million grant to the Peter MacCallum Cancer Centre. The major grant will support Peter Mac’s work with GE HealthCare’s next generation total body PET/CT technology*,…
Congratulations to Bionics Institute researchers Associate Professor Rachael Richardson and Associate Professor Andrew Wise on being awarded multi-million dollar grants to support their research.
Posted: 27 November 2024 A/Prof Rachael Richardson has received an AUD$1.15 million Ideas Grant from the National Health and Medical Research Council (NHMRC). As the CIA (Chief Investigator), Rachael and the research team are exploring the potential for…
Historic MOU Signed Between ACPCC and Gavi, Advancing Global Efforts to Eliminate Cervical Cancer
Posted: 27 November 2024 In a landmark event, the Australian Centre for the Prevention of Cervical Cancer (ACPCC) has signed a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance, to strengthen collaborative efforts in the global fight…
